February 26, 2021February 24, 2021
A Farewell Note to My Beloved Readers
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
So, the time has come. Here I am, three years after I sat down for the first time to write ... Read more
February 15, 2021February 11, 2021
A Light-giver Shares a Lesson in Emotional Honesty
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Have you ever noticed how the people with the most light to give are often those who have endured the ... Read more
February 1, 2021January 27, 2021
Embarking on a New Chapter While Cherishing the Value of Community
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
It’s surreal to ponder that our world has been living through a pandemic for a year now. That we’ve endured ... Read more
December 14, 2020December 9, 2020
Shedding My Sickness While Acknowledging Its Eternal Impact
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Just before the world changed overnight in March, I wrote a column titled “The Paradox of Healing.” In it, I ... Read more
November 16, 2020November 12, 2020
Sometimes Everything Works Out All Right
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
The other day, I chanced upon a poem called “Sometimes” that stopped me in my tracks and penetrated right through ... Read more
September 28, 2020September 24, 2020
Let’s Not Forget the Superheroes
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Lately, in the midst of all the insanity going on in the world and the ensuing, albeit dispiriting, headlines covering ... Read more
September 14, 2020September 10, 2020
Frozen Toes and Sleepless Nights: The Reality of Being a Cancer Survivor
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
For the past week, I have been living in what I can only describe as a state of unrelenting exhaustion. ... Read more
August 31, 2020August 27, 2020
Can a Break From Routine Induce Healing?
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
This is a question I found myself pondering the other week as I locked up my little flat and escaped ... Read more
August 17, 2020August 13, 2020
Reflections on My ‘Re-birthday’ and the Past Year of Recovery
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
By the time this column is published, the one-year anniversary of my lifesaving stem cell transplant will have come and ... Read more
July 27, 2020July 23, 2020
This Year Has Taught Me Gratitude
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
This week I’ve felt completely at a loss over what to write about. It happens sometimes. Usually there’s something on ... Read more
July 13, 2020July 9, 2020
Total Happiness Is Unobtainable, and That’s OK
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
I recently came to the realization that none of us will ever be totally happy. Upbeat way to start a ... Read more
June 29, 2020June 25, 2020
As I Befriend My Fear of Relapse, Fear Loses Its Power
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Being a cancer survivor is a complicated thing. It’s a lot of conflicting experiences at once. It’s walking down the ... Read more

June 9, 2017June 9, 2017

Community Oncologists Present 40 Abstracts on New Cancer Research at ASCO 2017

News

Community oncologists affiliated with the U.S. Oncology Network and U.S. Oncology Research shared findings from about 40 data presentations covering new approaches to several cancer specialties at the 53rd annual meeting of the American ... Read more

June 8, 2017June 8, 2017

T-Cell Therapy JCAR017 Eliminates Tumor Cells in Half of DLBCL Patients in Phase 1 Trial

News

Recently announced data from a Phase 1 trial for investigational T-cell therapy JCAR017 shows a high response rate for patients with relapsed or refractory CD19+ aggressive B-cell non-Hodgkin lymphoma (NHL), ... Read more

David Quessenberry Joins Practice for First Time Since Lymphoma Diagnosis

Phase 3 Study Soon to Test Opdivo and Adcetris Combo in Treating Relapsed Hodgkin’s Lymphoma Patients

News

Combining Bristol-Myers Squibb’s checkpoint inhibitor Opdivo (nivolumab) with Seattle Genetics’ antibody-therapy conjugate Adcetris (brentuximab vedotin) has been shown to be effective and safe in people with recurrent Hodgkin’s lymphoma (HL). Based on these ... Read more

June 5, 2017June 5, 2017

Aduro to Begin Testing ADU-S100 Combo in Phase 1b Trial for Lymphomas and Solid Tumors

News

U.S. regulators have cleared the way for Aduro Biotech to begin a Phase 1b clinical trial of a combination of ADU-S100 and Novartis’ PDR001 for treating lymphomas and advanced solid tumors or those that have spread. The green light ... Read more

June 2, 2017June 2, 2017

Potential Treatment for a Number of Blood Cancers, ASN002, Enters Phase 2 Trial

News

Following positive results in a dose–escalation trial with non-Hodgkin’s lymphoma (NHL) patients, a Phase 2 trial will now evaluate a new kinase inhibitor, ASN002, in the treatment of several hematological ... Read more

June 1, 2017May 31, 2017

The Impact Social Media had on My Experience with Lymphoma

Overcoming Adversity- a Column by Radiant Racheli

I recently was in a lesson at school where we spoke about the downfalls and negativity that social media attributed to our society. My knee-jerk reaction to the lesson was ... Read more

June 1, 2017June 1, 2017

Kiadis Hosts NYC Meeting to Discuss Candidate Therapy ATIR101, Risks of Haploidentical HSCT in Blood Cancer

News

Kiadis Pharma hosted a May 31 lunch meeting in New York to analyze the risks and benefits of haploidentical hematopoietic stem cell transplants (HSCT) in treating blood cancers. Two experts, Dr. Stephen ... Read more